We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.27B
AUM Growth
-$287M
Cap. Flow
-$382M
Cap. Flow %
-30.07%
Top 10 Hldgs %
34.31%
Holding
428
New
73
Increased
98
Reduced
156
Closed
77

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$26.5M
2
PFE icon
Pfizer
PFE
+$19.8M
3
SM icon
SM Energy
SM
+$19.7M
4
HD icon
Home Depot
HD
+$14M
5
ASML icon
ASML
ASML
+$11.5M

Top Sells

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$38.2M
2
DVN icon
Devon Energy
DVN
+$20.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$18.4M
4
JPM icon
JPMorgan Chase
JPM
+$17.9M
5
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$16.2M

Sector Composition

Rank Sector Weight
1 Energy 31.08%
2 Technology 12.45%
3 Healthcare 10.63%
4 Industrials 10.2%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEN
1
DELISTED
Denbury Inc.
DEN
$109M 8.57%
1,422,436
-164,399
-10% -$13M
EQT icon
2
EQT Corp
EQT
$33.8B
$59.4M 4.68%
2,737,616
-1,824,633
-40% -$38.2M
SM icon
3
SM Energy
SM
$7.96B
$50M 3.93%
1,695,544
+631,694
+59% +$19.7M
DVN icon
4
Devon Energy
DVN
$51.8B
$49.4M 3.89%
1,121,326
-493,454
-31% -$20.5M
CTRA
5
DELISTED
Coterra Energy
CTRA
$33.5M 2.63%
1,762,080
+1,268,866
+257% +$26.5M
ACN icon
6
Accenture
ACN
$85.7B
$32.8M 2.58%
79,132
-1,783
-2% -$650K
AR icon
7
Antero Resources
AR
$10.9B
$27.8M 2.19%
1,587,202
+218,210
+16% +$4.13M
PFE icon
8
Pfizer
PFE
$141B
$26.7M 2.1%
451,636
+399,197
+761% +$19.8M
ABBV icon
9
AbbVie
ABBV
$448B
$25M 1.97%
184,528
-18,226
-9% -$2.15M
HUBB icon
10
Hubbell
HUBB
$25.2B
$22.6M 1.78%
108,437
-1,522
-1% -$304K
VVV icon
11
Valvoline
VVV
$4.98B
$22.1M 1.74%
592,929
-327,272
-36% -$11.4M
FERG icon
12
Ferguson
FERG
$44.5B
$21.2M 1.67%
118,529
-2,373
-2% -$372K
RS icon
13
Reliance Steel & Aluminium
RS
$19.7B
$20.7M 1.63%
127,364
-2,238
-2% -$346K
INTU icon
14
Intuit
INTU
$77.8B
$19.2M 1.51%
29,910
-397
-1% -$245K
ING icon
15
ING
ING
$95.3B
$19M 1.5%
1,367,011
+267,890
+24% +$3.89M
UNH icon
16
UnitedHealth
UNH
$392B
$18M 1.42%
35,925
-321
-0.9% -$145K
EPSN icon
17
Epsilon Energy
EPSN
$171M
$18M 1.42%
3,168,133
HD icon
18
Home Depot
HD
$330B
$17M 1.33%
40,869
+36,778
+899% +$14M
MET icon
19
MetLife
MET
$60B
$16M 1.26%
255,721
-895
-0.3% -$56.2K
FOXA icon
20
Fox Class A
FOXA
$23.7B
$15.4M 1.21%
418,033
-80,819
-16% -$3.18M
HCA icon
21
HCA Healthcare
HCA
$82.5B
$14.8M 1.16%
57,515
-1,579
-3% -$386K
FANG icon
22
Diamondback Energy
FANG
$57.1B
$13.8M 1.08%
127,532
-1,525
-1% -$165K
MSFT icon
23
Microsoft
MSFT
$2.9T
$13.5M 1.06%
40,162
-952
-2% -$309K
STLA icon
24
Stellantis
STLA
$16.8B
$12.9M 1.01%
685,964
-11,575
-2% -$223K
KB icon
25
KB Financial Group
KB
$41.8B
$12.1M 0.95%
261,623
-4,161
-2% -$198K

Similar funds

Advisory Research's Q4 2021 Portfolio in Review

As of Q4 2021, Advisory Research held 428 positions worth $1.27B, down 18% from $1.56B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Advisory Research withdrew a net $382M in Q4 2021, closing 77 positions and reducing 156 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Energy at 31% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advisory Research opened a new position in Moelis & Co worth $4.4M.

  • Advisory Research's largest Q4 2021 buy was Moelis & Co: 70,442 shares worth $4.4M.
  • Advisory Research added most to Coterra Energy in Q4 2021, an estimated $26.5M increase.
  • Advisory Research's biggest Q4 2021 reduction was EQT Corp, cutting an estimated $38.2M.
  • Advisory Research fully exited Terminix Global Holdings, Inc. in Q4 2021, selling an estimated $11M.
  • Advisory Research's ten largest holdings make up 34% of its $1.27B portfolio in Q4 2021.
  • Advisory Research opened 73 new positions and closed 77 in Q4 2021.
  • Advisory Research's portfolio value fell 18% quarter-over-quarter to $1.27B.

Based on Advisory Research's 13F filing for Q4 2021, filed 11 Feb 2022.